• Kura Oncology appointed Jennifer Fulk as chief financial officer, effective Sept. 8, 2026.
• Fulk will join the senior leadership team, reporting to CEO Troy Wilson.
• She previously served as CFO of Soleno Therapeutics.
• Past roles include CFO of Talkspace, COO and CFO of 120Water.
• Earlier, she spent more than 15 years at Eli Lilly in senior finance roles across commercial operations, R&D portfolio management, investor relations, treasury.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080700PRIMZONEFULLFEED9822397) on September 08, 2026, and is solely responsible for the information contained therein.